(IN BRIEF) Scientists at The Institute of Cancer Research, London have identified features in some aggressive cancer cells that may make them vulnerable to ROCK inhibitors, a group of drugs already used to treat glaucoma. The research found relevant markers … Read the full press release →
Posted in Business, Education, Healthcare, Non Profit, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acute myeloid leukaemia, aggressive cancer cells, AML, Barts Cancer Institute, Barts Charity, biomarker discovery, breast cancer, Breast Cancer Now, Breast Cancer Now Toby Robins Research Centre, cancer cell biology, Cancer Cell Shape and Gene Patterns May Help Identify Patients Suitable for Glaucoma Drug Trials, cancer research, Cancer Research UK, cancer spread, cell scaffolding, clinical trials, Dr Simon Vincent, drug repurposing, drug sensitivity database, E-Cadherin, epithelial solid tumours, glaucoma drugs, ICR, ICR Study Opens Path Toward Testing ROCK Inhibitors in Personalised Cancer Treatment, invasive border, iScience, Jaume Barcelo, laboratory validation, melanoma, metastasis, metastatic cancer, molecular fingerprint, mouse studies, NFKB, NHS glaucoma treatment, non-epithelial solid tumours, patient biopsies, personalised cancer treatment, Professor Victoria Sanz Moreno, Queen Mary University of London, Rho kinase, ROCK inhibitors, rounded cancer cells, The Institute of Cancer Research London, treatment resistance, tumour growth, tumour inflammation, tumour invasion, tumour samples, UK Research and Innovation, UKRI, Worldwide Cancer Research
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
